Summary
This bill repeals the excise tax on the sale of a medical device by the manufacturer, producer, or importer. The medical device excise tax is a 2.3% excise tax on the sale of certain medical technology that was enacted as part of the Affordable Care Act.
Position
iBIO supports H.R.2207 and its companion bill S.692.
More Info